2016 American Transplant Congress Archives - Page 63 of 180

2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

Factors Predicting Risk for Antibody-Mediated Rejection in Highly Sensitized Pediatric Renal Transplants.

I. Kim,¹ J. Choi,¹ A. Vo,¹ S. Louie,¹ J. Mirocha,² S. Jordan,¹ E. Kamil,¹ D. Puliyanda.¹
Factors Predicting Tacrolimus Trough Variability After Lung Transplantation.

K. Boyle, M. Moranville, P. Shah.
Fate of Endogenous Alloreactive B Cells in Transplant Tolerance.

J. Chen,¹ J. Yang,¹ A. Akl,¹ Q. Wang,¹ D. Yin,¹ R. Sciammas,² A. Chong.¹
Fatigue, Pain, and Other Physical Symptoms of Living Liver Donors.

Z. Butt,¹ A. DiMartini,² Q. Liu,³ M. Simpson,⁴ A. Smith,^3,5 J. Zee,³ B. Gillespie,⁵ S. Holtzman,⁶ D. Ladner,¹ K. Olthoff,⁷ R. Fisher,⁸ S. Hafliger,⁹ C. Freise,¹⁰ M. Mandell,¹¹ M. Dew.²
Fatty Liver in Non-Hepatic Organ Transplantation.

N. Kemmer, A. Alsina.
Fc Receptor Binding Assay for Functional Assessment of HLA Antibodies: Initial Clinical Validation.

E. Woodle, A. Girnita.
Fecal Microbiota Transplant Results in Durable Changes to Host Microbiota That Correlate with Allograft Outcome.

C. Brinkman, L. Hittle, W. Fricke, E. Mongodin, J. Bromberg.
FGF and Wnt Signaling in Pancreatic Progenitor and Beta-Cell Growth.

S. Afelik,¹ N. Yonan,¹ B. Pool,² J. Jensen,² J. Oberholzer.¹
Fifty Is the New 40? An Argument to Uncap the MELD Score.

J. DiNorcia,¹ Y. Genyk,¹ K. Andreoni,⁴ W. Kim,³ J. Levitsky,⁵ D. Mulligan,⁶ R. Sung,⁷ M. Nadim.¹
Financial Burdens and Coping Mechanisms of Living Kidney Donors.

S. Li,¹ C. Thiessen,¹ J. Gannon,¹ D. Dobosz,¹ D. Gray,³ A. Mussell,³ K. Kennedy,² P. Reese,³ E. Gordon,¹ S. Kulkarni.²